Section Arrow
Quote
SLRX.NASDAQ
- Salarius Pharmaceuticals Inc
Quotes are at least 15-min delayed:2025/11/18 09:14 EST
Pre Market
Last
 0.9212
+0.0021 (+0.23%)
Bid
0.91
Ask
0.9212
High 0.9432 
Low 0.8787 
Volume 126629 
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
0.9191 
1-M High
4.216731 
Volume 
-- 
Bid
0.91
Ask
0.9212
Day Low
-- 
Open
-- 
1-M Low
0.8415 
Market Cap 
966.69K 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.89 
20-SMA 2.84 
50-SMA 3.76 
52-W High 108 
52-W Low 0.4501 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-23.70/-187.84
Enterprise Value
4.27M
Balance Sheet
Book Value Per Share
-0.79
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
838.14K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ZYMEZymeworks----0.000%-- 
Pre Market 23.6 -0.3 -1.26%
ZVRAZevra Therapeutics----0.000%19.53PE
Pre Market 9.1 -0.08 -0.87%
ZURAZura Bio Limited----0.000%5.54PE
Pre Market 3.86 -0.13 -3.26%
ZNTLZentalis Pharmaceuticals----0.000%-- 
Pre Market 1.34 +0.02 +1.52%
ZLABZai Lab Limited----0.000%-- 
Pre Market 20.88 -0.04 -0.19%
Quotes are at least 15-min delayed：2025/11/18 09:14 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.